BenQ Medical Technology (4116) — Financial Flexibility Index
BenQ Medical Technology (4116) has a Financial Flexibility Index of 0.06x as of June 2025. Free cash flow of NT$193.86 Million (operating CF NT$179.07 Million minus capex NT$14.79 Million) represents 0% of total liabilities (NT$3.14 Billion). Check BenQ Medical Technology (4116) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BenQ Medical Technology Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for BenQ Medical Technology across 8 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BenQ Medical Technology.
Annual Financial Flexibility Index for BenQ Medical Technology (2017–2024)
Year-by-year free cash flow to debt coverage for BenQ Medical Technology. Explore BenQ Medical Technology cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | NT$397.70 Million | NT$222.22 Million | NT$2.97 Billion | ▼ -41.8% |
| 2023 | 0.23x | NT$581.62 Million | NT$442.35 Million | NT$2.53 Billion | ▼ -13.0% |
| 2022 | 0.26x | NT$438.82 Million | NT$378.77 Million | NT$1.66 Billion | ▲ +46.5% |
| 2021 | 0.18x | NT$154.27 Million | NT$121.35 Million | NT$855.51 Million | ▼ -36.9% |
| 2020 | 0.29x | NT$193.85 Million | NT$151.48 Million | NT$677.80 Million | ▼ -12.1% |
| 2019 | 0.33x | NT$190.38 Million | NT$169.23 Million | NT$585.25 Million | ▲ +21.7% |
| 2018 | 0.27x | NT$157.46 Million | NT$126.10 Million | NT$589.30 Million | ▼ -31.4% |
| 2017 | 0.39x | NT$185.28 Million | NT$72.97 Million | NT$475.80 Million | — |